Bill Nye is back in his lab with NAF and Biogen—breaking down the science of Friedreich Ataxia in a new video series. WATCH NOW
Bill Nye is back in his lab with NAF and Biogen—breaking down the science of Friedreich Ataxia in a new video series. WATCH NOW
CENTRAL TIME ZONE
Join Biogen for a webinar on Thursday, August 28, at noon Eastern Time where Nicolas Folschweiller, PhD., Senior Medical Director, Clinical Development – Neuromuscular Development Unit, at Biogen, will share information about the upcoming BRAVE study: a global Phase 3 pediatric study for omaveloxolone.
Anyone considering participating in a clinical trial or trying a new medication should discuss the matter with their physician. The NAF does not endorse or recommend any particular studies or treatment options.
Register: Click here.
NAF hosts educational webinars about Ataxia presented by industry experts. Learn about important topics related to living with Ataxia. Webinars are complimentary for NAF members, with new sessions offered each month. Join NAF to receive invitations to upcoming Ataxia webinars. Visit www.ataxia.org/webinars to explore past webinars on a variety of topics.
